Dr. Hyun Kim
Claim this profileWashington University School of Medicine
About Hyun Kim
Education:
Obtained a BS in Molecular Cell Developmental Biology from UCLA in 2006.
Earned an MD from the University of Pittsburgh School of Medicine in 2012.
Completed Residency in Radiation Oncology at Thomas Jefferson University Hospital in 2017.
Experience:
Serves as Associate Professor of Radiation Oncology at Washington University School of Medicine.
Holds the position of Chief, Gastrointestinal Service and Chief, MR-Guided Radiotherapy at the same institution.
Focuses on gastrointestinal oncology, stereotactic body radiotherapy, and image-guided adaptive radiotherapy.
Researches in adaptive radiation therapy for gastrointestinal malignancies with an emphasis on real-time MR and CT guided treatment.
Area of expertise
Idiopathic Pulmonary Fibrosis
Hyun Kim has run 6 trials for Idiopathic Pulmonary Fibrosis. Some of their research focus areas include:
Rectal Cancer
Hyun Kim has run 6 trials for Rectal Cancer. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
University Of Minnesota
Clinical Trials Hyun Kim is currently running
Inhaled Treprostinil
for Pulmonary Fibrosis
Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.
Recruiting
1 award
Phase 3
11 criteria
177Lu-rhPSMA-10.1
for Prostate Cancer
This trial tests a new radioactive treatment for men with advanced prostate cancer that doesn't respond to hormone therapy. The treatment targets and kills cancer cells by delivering radiation directly to them. This new approach has shown promise in extending survival for men with advanced prostate cancer.
Recruiting
1 award
Phase 1 & 2
6 criteria
More about Hyun Kim
Clinical Trial Related
5 years of experience running clinical trials · Led 31 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Hyun Kim has experience with
- Placebo
- Ozanimod
- Radiation Therapy
- Inhaled Treprostinil
- MR Guided Radiation Therapy
- N-acetyl Cysteine
Breakdown of trials Hyun Kim has run
Idiopathic Pulmonary Fibrosis
Rectal Cancer
Stomach Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hyun Kim specialize in?
Hyun Kim focuses on Idiopathic Pulmonary Fibrosis and Rectal Cancer. In particular, much of their work with Idiopathic Pulmonary Fibrosis has involved rs3570920 TT positive patients, or patients who are undergoing treatment.
Is Hyun Kim currently recruiting for clinical trials?
Yes, Hyun Kim is currently recruiting for 6 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Hyun Kim has studied deeply?
Yes, Hyun Kim has studied treatments such as Placebo, Ozanimod, Radiation therapy.
What is the best way to schedule an appointment with Hyun Kim?
Apply for one of the trials that Hyun Kim is conducting.
What is the office address of Hyun Kim?
The office of Hyun Kim is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.